Is VRCI or ABDX more profitable?

Abingdon Health has a net margin of -33.88% compared to Verici Dx's net margin of -193.05%. Abingdon Health's return on equity of -55.91% beat Verici Dx's return on equity. Company Net Margins Return on Equity Return on Assets Verici Dx -193.05% -138.93% -26.14% Abingdon Health -33.88% -55.91% -17.93%

Which has preferable earnings and valuation, VRCI or GDR?

Verici Dx has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Verici Dx £3.66M 2.04 -£6.56M -£0.90 N/A genedrive £929K 19.88 -£21.22M -£0.79 N/A

Is VRCI or GDR more profitable?

Verici Dx has a net margin of -193.05% compared to genedrive's net margin of -500.75%. Verici Dx's return on equity of -138.93% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets Verici Dx -193.05% -138.93% -26.14% genedrive -500.75% -1,044.57% -74.09%

Is VRCI or YGEN more profitable?

Yourgene Health has a net margin of -27.55% compared to Verici Dx's net margin of -193.05%. Yourgene Health's return on equity of -27.06% beat Verici Dx's return on equity. Company Net Margins Return on Equity Return on Assets Verici Dx -193.05% -138.93% -26.14% Yourgene Health -27.55% -27.06% -6.71%

Which has stronger earnings & valuation, AGL or VRCI?

Verici Dx has higher revenue and earnings than ANGLE. ANGLE is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ANGLE £2.62M 2.89 -£21.76M -£4.80 N/A Verici Dx £3.66M 2.04 -£6.56M -£0.90 N/A

Is AGL or VRCI more profitable?

Verici Dx has a net margin of -193.05% compared to ANGLE's net margin of -1,444.04%. Verici Dx's return on equity of -138.93% beat ANGLE's return on equity. Company Net Margins Return on Equity Return on Assets ANGLE -1,444.04% -191.36% -29.89% Verici Dx -193.05% -138.93% -26.14%

Is GENI or VRCI more profitable?

GENinCode has a net margin of -185.47% compared to Verici Dx's net margin of -193.05%. Verici Dx's return on equity of -138.93% beat GENinCode's return on equity. Company Net Margins Return on Equity Return on Assets GENinCode -185.47% -409.40% -63.99% Verici Dx -193.05% -138.93% -26.14%

Verici Dx (VRCI) Competitors

GBX 0.25 +0.03 (+11.11%)

As of 06:48 AM Eastern

Compare

VRCI vs. ABDX, GDR, YGEN, AGL, and GENI

Should you buy Verici Dx stock or one of its competitors? MarketBeat compares Verici Dx with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Verici Dx include Abingdon Health (ABDX), genedrive (GDR), Yourgene Health (YGEN), ANGLE (AGL), and GENinCode (GENI).

How does Verici Dx compare to Abingdon Health?

Verici Dx (LON:VRCI) and Abingdon Health (LON:ABDX) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership.

Abingdon Health has a net margin of -33.88% compared to Verici Dx's net margin of -193.05%. Abingdon Health's return on equity of -55.91% beat Verici Dx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Verici Dx	-193.05%	-138.93%	-26.14%
Abingdon Health	-33.88%	-55.91%	-17.93%

In the previous week, Abingdon Health's average media sentiment score of 0.76 beat Verici Dx's score of 0.00 indicating that Abingdon Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Verici Dx	Neutral
Abingdon Health	Positive

7.9% of Verici Dx shares are held by institutional investors. Comparatively, 3.7% of Abingdon Health shares are held by institutional investors. 1.3% of Verici Dx shares are held by insiders. Comparatively, 8.0% of Abingdon Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Verici Dx has a beta of 1.256, indicating that its share price is 26% more volatile than the broader market. Comparatively, Abingdon Health has a beta of 0.16, indicating that its share price is 84% less volatile than the broader market.

Abingdon Health has higher revenue and earnings than Verici Dx. Abingdon Health is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Verici Dx	£3.66M	2.04	-£6.56M	-£0.90	N/A
Abingdon Health	£9.57M	2.83	-£796.37K	-£0.81	N/A

Summary

Abingdon Health beats Verici Dx on 9 of the 12 factors compared between the two stocks.

How does Verici Dx compare to genedrive?

Verici Dx (LON:VRCI) and genedrive (LON:GDR) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, media sentiment, profitability, institutional ownership, valuation and earnings.

7.9% of Verici Dx shares are held by institutional investors. Comparatively, 0.1% of genedrive shares are held by institutional investors. 1.3% of Verici Dx shares are held by insiders. Comparatively, 29.0% of genedrive shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Verici Dx has a net margin of -193.05% compared to genedrive's net margin of -500.75%. Verici Dx's return on equity of -138.93% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Verici Dx	-193.05%	-138.93%	-26.14%
genedrive	-500.75%	-1,044.57%	-74.09%

Verici Dx has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Verici Dx	£3.66M	2.04	-£6.56M	-£0.90	N/A
genedrive	£929K	19.88	-£21.22M	-£0.79	N/A

Verici Dx has a beta of 1.256, suggesting that its stock price is 26% more volatile than the broader market. Comparatively, genedrive has a beta of 0.989, suggesting that its stock price is 1% less volatile than the broader market.

In the previous week, genedrive had 3 more articles in the media than Verici Dx. MarketBeat recorded 3 mentions for genedrive and 0 mentions for Verici Dx. genedrive's average media sentiment score of 0.37 beat Verici Dx's score of 0.00 indicating that genedrive is being referred to more favorably in the news media.

Company	Overall Sentiment
Verici Dx	Neutral
genedrive	Neutral

Summary

Verici Dx beats genedrive on 8 of the 13 factors compared between the two stocks.

How does Verici Dx compare to Yourgene Health?

Verici Dx (LON:VRCI) and Yourgene Health (LON:YGEN) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

Verici Dx has higher earnings, but lower revenue than Yourgene Health. Verici Dx is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Verici Dx	£3.66M	2.04	-£6.56M	-£0.90	N/A
Yourgene Health	£29.67M	0.00	-£8.17M	-£0.01	N/A

Yourgene Health has a net margin of -27.55% compared to Verici Dx's net margin of -193.05%. Yourgene Health's return on equity of -27.06% beat Verici Dx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Verici Dx	-193.05%	-138.93%	-26.14%
Yourgene Health	-27.55%	-27.06%	-6.71%

In the previous week, Verici Dx's average media sentiment score of 0.00 equaled Yourgene Health'saverage media sentiment score.

Company	Overall Sentiment
Verici Dx	Neutral
Yourgene Health	Neutral

Verici Dx has a beta of 1.256, indicating that its stock price is 26% more volatile than the broader market. Comparatively, Yourgene Health has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market.

7.9% of Verici Dx shares are owned by institutional investors. Comparatively, 23.3% of Yourgene Health shares are owned by institutional investors. 1.3% of Verici Dx shares are owned by company insiders. Comparatively, 64.4% of Yourgene Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Yourgene Health beats Verici Dx on 7 of the 10 factors compared between the two stocks.

How does Verici Dx compare to ANGLE?

ANGLE (LON:AGL) and Verici Dx (LON:VRCI) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations and earnings.

Verici Dx has higher revenue and earnings than ANGLE. ANGLE is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ANGLE	£2.62M	2.89	-£21.76M	-£4.80	N/A
Verici Dx	£3.66M	2.04	-£6.56M	-£0.90	N/A

In the previous week, ANGLE's average media sentiment score of 0.76 beat Verici Dx's score of 0.00 indicating that ANGLE is being referred to more favorably in the media.

Company	Overall Sentiment
ANGLE	Positive
Verici Dx	Neutral

ANGLE has a beta of 0.22, meaning that its stock price is 78% less volatile than the broader market. Comparatively, Verici Dx has a beta of 1.256, meaning that its stock price is 26% more volatile than the broader market.

17.5% of ANGLE shares are owned by institutional investors. Comparatively, 7.9% of Verici Dx shares are owned by institutional investors. 2.7% of ANGLE shares are owned by insiders. Comparatively, 1.3% of Verici Dx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Verici Dx has a net margin of -193.05% compared to ANGLE's net margin of -1,444.04%. Verici Dx's return on equity of -138.93% beat ANGLE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ANGLE	-1,444.04%	-191.36%	-29.89%
Verici Dx	-193.05%	-138.93%	-26.14%

Summary

Verici Dx beats ANGLE on 8 of the 12 factors compared between the two stocks.

How does Verici Dx compare to GENinCode?

GENinCode (LON:GENI) and Verici Dx (LON:VRCI) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

In the previous week, GENinCode's average media sentiment score of 0.00 equaled Verici Dx'saverage media sentiment score.

Company	Overall Sentiment
GENinCode	Neutral
Verici Dx	Neutral

GENinCode has a beta of 0.593, suggesting that its share price is 41% less volatile than the broader market. Comparatively, Verici Dx has a beta of 1.256, suggesting that its share price is 26% more volatile than the broader market.

11.4% of GENinCode shares are owned by institutional investors. Comparatively, 7.9% of Verici Dx shares are owned by institutional investors. 8.4% of GENinCode shares are owned by insiders. Comparatively, 1.3% of Verici Dx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

GENinCode has higher earnings, but lower revenue than Verici Dx. GENinCode is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GENinCode	£3.08M	2.04	-£6.10M	-£2.08	N/A
Verici Dx	£3.66M	2.04	-£6.56M	-£0.90	N/A

GENinCode has a net margin of -185.47% compared to Verici Dx's net margin of -193.05%. Verici Dx's return on equity of -138.93% beat GENinCode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GENinCode	-185.47%	-409.40%	-63.99%
Verici Dx	-193.05%	-138.93%	-26.14%

Summary

Verici Dx beats GENinCode on 6 of the 11 factors compared between the two stocks.

Get Verici Dx News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VRCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

VRCI vs. The Competition

Export

Metric	Verici Dx	Life Sciences Tools & Services Industry	Healthcare Sector	LON Exchange
Market Cap	£7.47M	£9.22B	£6.93B	£2.87B
Dividend Yield	N/A	1.47%	2.60%	6.13%
P/E Ratio	-0.28	62.26	281.16	369.49
Price / Sales	2.04	260.94	577.53	83,955.53
Price / Cash	1.31	25.96	71.79	27.89
Price / Book	0.06	38.11	12.86	7.07
Net Income	-£6.56M	£57.47B	£3.49B	£5.89B
7 Day Performance	-16.67%	1.32%	2.64%	1.18%
1 Month Performance	-28.77%	-2.33%	-2.64%	0.90%
1 Year Performance	-50.50%	19.15%	76.00%	75.31%

Verici Dx Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
VRCI Verici Dx	N/A	GBX 0.25 +11.1%	N/A	-56.4%	£7.47M	£3.66M	N/A	19	Negative News Gap Up
ABDX Abingdon Health	N/A	GBX 10 +5.3%	N/A	+61.4%	£25.11M	£9.57M	N/A	84	Gap Down
GDR genedrive	N/A	GBX 1.10 +7.8%	N/A	+0.6%	£17.66M	£929K	N/A	43	News Coverage Gap Up
YGEN Yourgene Health	N/A	N/A	N/A	N/A	£16.43M	£29.67M	N/A	253
AGL ANGLE	N/A	GBX 2.35 -11.3%	N/A	-59.8%	£7.58M	£2.62M	N/A	650	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:VRCI) was last updated on 8/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Verici Dx (VRCI) Competitors

VRCI vs. ABDX, GDR, YGEN, AGL, and GENI

How does Verici Dx compare to Abingdon Health?

Summary

How does Verici Dx compare to genedrive?

Summary

How does Verici Dx compare to Yourgene Health?

Summary

How does Verici Dx compare to ANGLE?

Summary

How does Verici Dx compare to GENinCode?

Summary

New MarketBeat Followers Over Time

VRCI vs. The Competition

Verici Dx Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Verici Dx (VRCI) Competitors

VRCI vs. ABDX, GDR, YGEN, AGL, and GENI

How does Verici Dx compare to Abingdon Health?

Is VRCI or ABDX more profitable?

Does the media prefer VRCI or ABDX?

Do insiders and institutionals believe in VRCI or ABDX?

Which has more volatility & risk, VRCI or ABDX?

Which has preferable earnings and valuation, VRCI or ABDX?

Summary

How does Verici Dx compare to genedrive?

Do institutionals and insiders believe in VRCI or GDR?

Is VRCI or GDR more profitable?

Which has preferable earnings and valuation, VRCI or GDR?

Which has more risk and volatility, VRCI or GDR?

Does the media favor VRCI or GDR?

Summary

How does Verici Dx compare to Yourgene Health?

Which has stronger valuation and earnings, VRCI or YGEN?

Is VRCI or YGEN more profitable?

Does the media favor VRCI or YGEN?

Which has more risk & volatility, VRCI or YGEN?

Do insiders and institutionals believe in VRCI or YGEN?

Summary

How does Verici Dx compare to ANGLE?

Which has stronger earnings & valuation, AGL or VRCI?

Does the media refer more to AGL or VRCI?

Which has more risk & volatility, AGL or VRCI?

Do insiders and institutionals believe in AGL or VRCI?

Is AGL or VRCI more profitable?

Summary

How does Verici Dx compare to GENinCode?

Does the media prefer GENI or VRCI?

Which has more volatility & risk, GENI or VRCI?

Do institutionals and insiders hold more shares of GENI or VRCI?

Which has better earnings & valuation, GENI or VRCI?

Is GENI or VRCI more profitable?

Summary

New MarketBeat Followers Over Time

VRCI vs. The Competition

Verici Dx Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools